Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis
Background: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. Objective: We aim...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848221140659 |
_version_ | 1811311642239041536 |
---|---|
author | Øyvind Steinsbø Arne Carlsen Ole Gunnar Aasprong Lars Aabakken Espen Tvedt-Gundersen Steinar Bjørkhaug Rune Gjerde Lars Normann Karlsen Tore Grimstad |
author_facet | Øyvind Steinsbø Arne Carlsen Ole Gunnar Aasprong Lars Aabakken Espen Tvedt-Gundersen Steinar Bjørkhaug Rune Gjerde Lars Normann Karlsen Tore Grimstad |
author_sort | Øyvind Steinsbø |
collection | DOAJ |
description | Background: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. Objective: We aimed to assess the deep and complete remission rates after 3 months of conventional treatment in patients with newly diagnosed UC with moderate to severe endoscopic activity. We also aimed to investigate whether selected clinical and biochemical variables at baseline were associated with complete remission status after 3 months. Design: This was a prospective cohort study. Methods: Newly diagnosed patients with active UC commencing 5-aminosalicylate, corticosteroid, and/or azathioprine treatment were consecutively included. Clinical, biochemical, endoscopic, and histological data were collected at baseline and after 3 months. Rates of clinical remission (Partial Mayo Score ⩽ 2), mucosal healing (Mayo Endoscopic Score ⩽ 1), and histologic healing (Nancy Index ⩽ 1) were determined. Deep remission was assessed as clinical remission plus mucosal healing and complete remission as deep remission plus histologic healing. Predictors of complete remission were identified by logistic regression. Results: A total of 180 patients were included in the study. Deep remission and complete remission occurred in 62.8% and 42.2% of patients, respectively. Thus, of patients in deep remission one-third had persistent histologic activity. Histologic activity in mucosally healed patients was associated with higher symptom scores and faecal calprotectin levels. Of baseline variables, less endoscopic distribution and disease activity showed strongest association with achieving complete remission, and limited distribution in combination with moderate activity gave highest odds for complete remission (odds ratio: 4.1, 95% confidence interval: 7.69–2.18). Conclusion: In patients with mucosal healing, persistent histologic activity was a common finding and was associated with increased disease activity. Pancolitis and severe inflammatory activity at baseline were associated with lower complete remission rates. |
first_indexed | 2024-04-13T10:22:26Z |
format | Article |
id | doaj.art-faa0db8c67e1476d862b657803474e89 |
institution | Directory Open Access Journal |
issn | 1756-2848 |
language | English |
last_indexed | 2024-04-13T10:22:26Z |
publishDate | 2022-12-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Therapeutic Advances in Gastroenterology |
spelling | doaj.art-faa0db8c67e1476d862b657803474e892022-12-22T02:50:28ZengSAGE PublishingTherapeutic Advances in Gastroenterology1756-28482022-12-011510.1177/17562848221140659Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitisØyvind SteinsbøArne CarlsenOle Gunnar AasprongLars AabakkenEspen Tvedt-GundersenSteinar BjørkhaugRune GjerdeLars Normann KarlsenTore GrimstadBackground: Endoscopic and histological activity scores in ulcerative colitis (UC) are associated with clinical outcomes and have become important targets of clinical trials. However, these endpoints have been scarcely investigated in patients receiving only conventional treatment. Objective: We aimed to assess the deep and complete remission rates after 3 months of conventional treatment in patients with newly diagnosed UC with moderate to severe endoscopic activity. We also aimed to investigate whether selected clinical and biochemical variables at baseline were associated with complete remission status after 3 months. Design: This was a prospective cohort study. Methods: Newly diagnosed patients with active UC commencing 5-aminosalicylate, corticosteroid, and/or azathioprine treatment were consecutively included. Clinical, biochemical, endoscopic, and histological data were collected at baseline and after 3 months. Rates of clinical remission (Partial Mayo Score ⩽ 2), mucosal healing (Mayo Endoscopic Score ⩽ 1), and histologic healing (Nancy Index ⩽ 1) were determined. Deep remission was assessed as clinical remission plus mucosal healing and complete remission as deep remission plus histologic healing. Predictors of complete remission were identified by logistic regression. Results: A total of 180 patients were included in the study. Deep remission and complete remission occurred in 62.8% and 42.2% of patients, respectively. Thus, of patients in deep remission one-third had persistent histologic activity. Histologic activity in mucosally healed patients was associated with higher symptom scores and faecal calprotectin levels. Of baseline variables, less endoscopic distribution and disease activity showed strongest association with achieving complete remission, and limited distribution in combination with moderate activity gave highest odds for complete remission (odds ratio: 4.1, 95% confidence interval: 7.69–2.18). Conclusion: In patients with mucosal healing, persistent histologic activity was a common finding and was associated with increased disease activity. Pancolitis and severe inflammatory activity at baseline were associated with lower complete remission rates.https://doi.org/10.1177/17562848221140659 |
spellingShingle | Øyvind Steinsbø Arne Carlsen Ole Gunnar Aasprong Lars Aabakken Espen Tvedt-Gundersen Steinar Bjørkhaug Rune Gjerde Lars Normann Karlsen Tore Grimstad Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis Therapeutic Advances in Gastroenterology |
title | Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis |
title_full | Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis |
title_fullStr | Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis |
title_full_unstemmed | Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis |
title_short | Histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis |
title_sort | histologic healing and factors associated with complete remission following conventional treatment in ulcerative colitis |
url | https://doi.org/10.1177/17562848221140659 |
work_keys_str_mv | AT øyvindsteinsbø histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT arnecarlsen histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT olegunnaraasprong histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT larsaabakken histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT espentvedtgundersen histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT steinarbjørkhaug histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT runegjerde histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT larsnormannkarlsen histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis AT toregrimstad histologichealingandfactorsassociatedwithcompleteremissionfollowingconventionaltreatmentinulcerativecolitis |